Cancer Biology & Therapy, Volume 12, Issue 5 (2011)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Cancer Biology & Therapy, Volume 12, Issue 5 (2011)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Volume 12, 2011 Vol 11, 2011 Vol 10, 2010 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Bedside to Bench Report

Article
Circulating tumor cells count and characterization in a male breast cancer patient
Paola Gazzaniga, Giuseppe Naso, Cristina Raimondi, Angela Gradilone, Antonella Palazzo, Orietta Gandini, Arianna Petracca, Chiara Nicolazzo, Enrico Cortesi & Luigi Frati
Pages: 379-382
Published online: 01 Sep 2011
AbstractforCirculating tumor cells count and characterization in a male breast cancer patient | PDF (1 MB)
  • 398 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Polymorphisms in the hypoxia-inducible factor-1α gene confer susceptibility to pancreatic cancer
Xiuchao Wang, Yingwei Liu, He Ren, Zhanna Yuan, Shasha Li, Jun Sheng, Tiansuo Zhao, Yong Chen, Fenghua Liu, Feng Wang, He Huang & Jihui Hao
Pages: 383-387
Published online: 01 Sep 2011
AbstractforPolymorphisms in the hypoxia-inducible factor-1α gene confer susceptibility to pancreatic cancer | PDF (1.2 MB)
  • 418 Views
  • 37 CrossRef citations
  • 0Altmetric
Free Access
Article
Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer
Kai Song, Qin Li, Zhen-Zhen Jiang, Chao-Wei Guo & Ping Li
Pages: 388-398
Published online: 01 Sep 2011
AbstractforHeparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer | PDF (3.5 MB) | Supplemental
  • 425 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access
Article
Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats
Roger Yazbeck, Gordon S. Howarth, Luis Borges, Mark S. Geier, Cassie L. Smith, Geoffrey P. Davidson & Ross N. Butler
Pages: 399-406
Published online: 01 Sep 2011
AbstractforNon-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats | PDF (2.1 MB)
  • 245 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access
Article
Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer
Ibrahim A. Aljuffali, Jason N. Mock, Leah J. Costyn, Ha Nguyen, Tamas Nagy, Brian S. Cummings & Robert D. Arnold
Pages: 407-420
Published online: 01 Sep 2011
AbstractforEnhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer | Full Text | References | PDF (7 MB) | Supplemental
  • 946 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access
Article
p34SEI-1 inhibits ROS-induced cell death through suppression of ASK1
Seung-Woo Hong, Jae-Sik Shin, Young-Min Lee, Dong-Gil Kim, Sok-Young Lee, Dok Hyun Yoon, Seong-Yun Jung, Jung Jin Hwang, Seung-Jin Lee, Dong-Hyung Cho, Yong-Sang Hong, Tae-Won Kim, Dong-Hoon Jin & Won-Keun Lee
Pages: 421-426
Published online: 01 Sep 2011
Abstractforp34SEI-1 inhibits ROS-induced cell death through suppression of ASK1 | PDF (1.5 MB) | Supplemental
  • 387 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains
Yasser Heakal, Matthew P. Woll, Todd Fox, Kelly Seaton, Robert Levenson & Mark Kester
Pages: 427-435
Published online: 01 Sep 2011
AbstractforNeurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains | Full Text | References | PDF (2.8 MB)
  • 928 Views
  • 26 CrossRef citations
  • 0Altmetric
Free Access
Article
Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab
Toni M. Brand, Emily F. Dunn, Mari Iida, Rebecca A. Myers, Kellie T. Kostopoulos, Chunrong Li, Chimera R. Peet & Deric L. Wheeler
Pages: 436-446
Published online: 01 Sep 2011
AbstractforErlotinib is a viable treatment for tumors with acquired resistance to cetuximab | Full Text | References | PDF (3.4 MB)
  • 800 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Article
Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization
Marina Di Domenico, Angela Santoro, Carmela Ricciardi, Mirella Iaccarino, Stefania Iaccarino, Mariagrazia Freda, Antonia Feola, Francesca Sanguedolce, Simona Losito, Daniela Pasquali, Attilio Di Spiezio Sardo, Giuseppe Bifulco, Carmine Nappi, Pantaleo Bufo, Maurizio Guida, Gaetano De Rosa, Alberto Abbruzzese, Michele Caraglia & Giuseppe Pannone
Pages: 447-457
Published online: 01 Sep 2011
AbstractforEpigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization | PDF (2.6 MB)
  • 549 Views
  • 33 CrossRef citations
  • 0Altmetric
Free Access
Article
Sunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation
Woo-Jin Jeong, Ji-Hun Mo, Min Woo Park, Ik Joon Choi, Soo-Youn An, Eun-Hee Jeon & Soon-Hyun Ahn
Pages: 458-465
Published online: 01 Sep 2011
AbstractforSunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation | PDF (2.2 MB)
  • 540 Views
  • 26 CrossRef citations
  • 0Altmetric
Free Access

Explore articles